Initial transfusion frequency and survival in myelodysplastic syndromes: hopping onto a fast train to nowhere

“I hear the train a comin’. It's rolling round the bend. And I ain't seen the sunshine since I don't know when” [1].Johnny Cash, Folsom Prison BluesAnemia has long been one of the defining characte...

[1]  S. Goel,et al.  Myelodysplastic syndromes: Where do we stand? , 2016 .

[2]  J. Neukirchen.  Iron chelation in MDS: still a controversial issue. , 2014, Leukemia research.

[3]  R. Wells,et al.  Initial transfusion intensity predicts survival in myelodysplastic syndrome , 2014, Leukemia & lymphoma.

[4]  Francisco Cervantes,et al.  European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. , 2013, Blood.

[5]  S. Gore,et al.  Iron chelation therapy in myelodysplastic syndromes: where do we stand? , 2013, Expert review of hematology.

[6]  G. Ossenkoppele,et al.  P-095 A five parameter based flow cytometric scoring system refines the revised International Prognostic Scoring System for myelodysplastic syndromes , 2013 .

[7]  A. Jankowska,et al.  SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. , 2012, Blood.

[8]  Luca Malcovati,et al.  Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.

[9]  M. Cazzola,et al.  Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS) , 2011, Haematologica.

[10]  D. Steensma.  The Relevance of Iron Overload and the Appropriateness of Iron Chelation Therapy for Patients with Myelodysplastic Syndromes: A Dialogue and Debate , 2011, Current hematologic malignancy reports.

[11]  A. Stamatoullas,et al.  Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe Francophone des Myélodysplasies). , 2010, Leukemia research.

[12]  J. Warner,et al.  Faculty Opinions recommendation of Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. , 2008 .

[13]  T. Golub,et al.  Identification of RPS14 as a 5q- syndrome gene by RNA interference screen , 2007, Nature.

[14]  H. Kantarjian,et al.  A prognostic score for patients with lower risk myelodysplastic syndrome , 2008, Leukemia.

[15]  M. Cazzola,et al.  Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Cazzola,et al.  Myelodysplastic syndromes--coping with ineffective hematopoiesis. , 2005, The New England journal of medicine.

[17]  T Hamblin,et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.

[18]  D. Machin,et al.  Myelodysplastic syndromes: a scoring system with prognostic significance , 1985, British journal of haematology.